Related Experiment Videos
Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot
V Bonicalzi1, S Canavero, F Cerutti
1Department of Neurosciences, Institute of Anesthesia, University of Turin, Torino, Italy.
Surgery
|October 6, 1997
Summary
Lamotrigine effectively reduced postoperative pain and analgesic use in a pilot study. This antiepileptic drug shows promise for managing pain after surgery.
Area of Science:
- Anesthesiology
- Pharmacology
- Pain Management
Background:
- Postoperative pain remains a significant clinical challenge, often undertreated.
- Lamotrigine, an antiepileptic drug, possesses potential analgesic properties attributed to its antisodium and antiglutamatergic mechanisms.
- This study investigated lamotrigine's efficacy in preventing postoperative pain.
Purpose of the Study:
- To assess the effectiveness of lamotrigine in mitigating postoperative pain.
- To evaluate the impact of lamotrigine on the need for supplemental analgesics.
Main Methods:
- A double-blind, randomized, placebo-controlled pilot study was conducted.
- Thirty patients undergoing transurethral prostatectomy under spinal anesthesia participated.
- Participants received either 200 mg of lamotrigine or a placebo one hour prior to spinal anesthesia.
Main Results:
- Lamotrigine administration resulted in a statistically significant reduction in total analgesic consumption (p < 0.01).
- Visual analog scale (VAS) pain scores were significantly lower in the lamotrigine group at 2 hours (p = 0.04), 4 hours (p < 0.01), and 6 hours (p = 0.04) postoperatively.
- These findings indicate a clear analgesic effect of lamotrigine in the early postoperative period.
Conclusions:
- Lamotrigine demonstrates potential as an effective agent for reducing postoperative pain.
- The study suggests lamotrigine may be a valuable addition to multimodal pain management strategies following surgery.